Mefloquine the drug's very long half-life, the Centers for Disease Control originally recommended a mefloquine dosage of 250 mg every two weeks; however, this caused an unacceptably high malaria rate in the Peace Corps volunteers who participated in the approval study, so the drug regimen was switched to once a week. The first randomized, controlled trial on a mixed population was performed in 2001. Prophylaxis with mefloquine was compared to prophylaxis with atovaquone-proguanil. Roughly 67% of participants in the mefloquine arm reported greater than or equal to one adverse event, vs 71% in the atovaquone-proguanil arm. In the mefloquine arm, 5%
Israel Center for the Treatment of Psychotrauma Israel Center for the Treatment of Psychotrauma The Israel Center for the Treatment of Psychotrauma (ICTP) affiliated with Herzog Hospital in Jerusalem, Israel, is a community-based trauma center The Israel Center for the Treatment of Psychotrauma was established in 1989 to improve the level of trauma-related services in Israel and around the world. ICTP has developed a comprehensive range of clinical and community-based services. ICTP is today involved in the research and treatment of the widespread effects of trauma caused by terrorism, war and natural disaster. ICTP has been active in its present form since 1989, but draws on a